Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | PRKCA | P17252 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5171201 | 1.00 | CA1 (0.40) | CA1CA9LMNATSHRCYP1A2 | |
| SCHEMBL447330 | 1.00 | CA1 (0.40) | CA1CA9LMNATSHRCYP1A2 | |
| SCHEMBL10626844 | 0.98 | CA1 (0.39) | CA1CA9LMNATSHRCYP1A2 | |
| SCHEMBL6753672 | 0.88 | CA1 (0.33) | CA1CA9LMNATSHR | |
| SCHEMBL5304809 | 0.82 | CA1 (0.43) | CA1CA9TSHRCYP1A2PRKCA | |
| SCHEMBL9041353 | 0.82 | CA1 (0.39) | CA1CA9CYP1A2PRKCA | |
| SCHEMBL7747592 | 0.82 | CA1 (0.43) | CA1CA9TSHRCYP1A2PRKCA | |
| SCHEMBL5150624 | 0.80 | CA1 (0.30) | CA1CA9 | |
| Cyclohexene SCHEMBL6866890 | 0.79 | ATM (0.32) | — | |
| SCHEMBL14889302 | 0.77 | CA1 (0.35) | CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1504002-B1 | METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE BETA-AMINOKETONES AND OPTICALLY ACTIVE 1,3-AMINOALCOHOLS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2012-12-19 | — | — | EP | claimed |
| EP-1504002-A1 | OPTICALLY ACTIVE &bgr;-AMINOKETONES, OPTICALLY ACTIVE 1,3-AMINOALCOHOLS AND METHOD FOR THE PRODUCTION THEREOF | Aventis Pharma Deutschland GmbH (DE) | 2005-02-09 | — | — | EP | claimed |
| WO-2003093259-A1 | OPTICALLY ACTIVE β-AMINOKETONES, OPTICALLY ACTIVE 1,3-AMINOALCOHOLS AND METHOD FOR THE PRODUCTION THEREOF | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-11-13 | — | — | WO | claimed |
| EP-1504002-B1 | METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE BETA-AMINOKETONES AND OPTICALLY ACTIVE 1,3-AMINOALCOHOLS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2012-12-19 | — | — | EP | disclosed |
| EP-1299342-B1 | METHOD FOR PRODUCING 3,3-DIARYLPROPYLAMINES | SANOL ARZNEI SCHWARZ GMBH (DE) | 2007-05-02 | — | — | EP | disclosed |
| EP-1504002-A1 | OPTICALLY ACTIVE &bgr;-AMINOKETONES, OPTICALLY ACTIVE 1,3-AMINOALCOHOLS AND METHOD FOR THE PRODUCTION THEREOF | Aventis Pharma Deutschland GmbH (DE) | 2005-02-09 | — | — | EP | disclosed |
| WO-2003093259-A1 | OPTICALLY ACTIVE β-AMINOKETONES, OPTICALLY ACTIVE 1,3-AMINOALCOHOLS AND METHOD FOR THE PRODUCTION THEREOF | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-11-13 | — | — | WO | disclosed |
| EP-1299342-A1 | METHOD FOR PRODUCING 3,3-DIARYLPROPYLAMINES | SCHWARZ PHARMA AG (DE) | 2003-04-09 | — | — | EP | disclosed |
| WO-2002004399-A1 | METHOD FOR PRODUCING 3,3-DIARYLPROPYLAMINES | SCHWARZ PHARMA AG (DE) | 2002-01-17 | — | — | WO | disclosed |